87. de la Porte PW, Lok DJ, van Veldhuisen DJ, van Wijngaarden J, Cornel JH, Zuithoff NP et al. Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer- Alkmaar heart failure study. Heart. 2007; 93(7):819-25 88. de Lusignan S, Wells S, Johnson P, Meredith K, Leatham E. Compliance and effectiveness of 1 year's home telemonitoring. The report of a pilot study of patients with chronic heart failure. European Journal of Heart Failure. 2001; 3(6):723-30 89. DeBusk RF, Miller NH, Parker KM, Bandura A, Kraemer HC, Cher DJ et al. Care management for low-risk patients with heart failure: a randomized, controlled trial. Annals of Internal 90. Del Sindaco D, Pulignano G, Di Lenarda A, Tarantini L, Cioffi G, Tolone S et al. Role of a multidisciplinary program in improving outcomes in cognitively impaired heart failure older patients. Monaldi Archives for Chest Disease. 2012; 78(1):20-8 91. Del Sindaco D, Pulignano G, Minardi G, Apostoli A, Guerrieri L, Rotoloni M et al. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure. Journal of Cardiovascular Medicine. 2007; 8(5):324-9 92. Dendale P, De Keulenaer G, Troisfontaines P, Weytjens C, Mullens W, Elegeert I et al. Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (TElemonitoring in the MAnagement of Heart Failure) study. European Journal of Heart 93. Department of Health. NHS reference costs 2015-16. 2016. Available from: accessed: 24/01/2018. 94. Desai AS, Lewis EF, Li R, Solomon SD, Assmann SF, Boineau R et al. Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction. 